Peng You, Li Chen, Luo Ding-Cun, Ding Jin-Wang, Zhang Wo, Pan Gang
Department of Oncological Surgery, Hangzhou First People's Hospital, Hangzhou 310006, China.
Department of General Surgery, Wuxi Second People's Hospital, Wuxi 214000, China.
Molecules. 2014 Aug 5;19(8):11586-99. doi: 10.3390/molecules190811586.
This study screened microRNAs (miRNAs) that are abnormally expressed in papillary thyroid carcinoma (PTC) tissues to identify PTC and nodular goiter and the degree of PTC malignancy. A total of 51 thyroid tumor tissue specimens paired with adjacent normal thyroid tissues were obtained from the Department of Surgical Oncology of Hangzhou First People's Hospital from June-December 2011. miRNA expression profiles were examined by microarrays and validated by quantitative real-time PCR (qRT-PCR). Expression levels of the miRNAs were analyzed to assess if they were associated with selected clinicopathological features. Eleven miRNAs were significantly differentially expressed between nodular goiter and PTC and between highly invasive and low invasive PTC. miR-199b-5p and miR-30a-3p were significantly differentially expressed among the three groups. miR-30a-3p, miR-122-5p, miR-136-5p, miR-146b-5p and miR-199b-5p were selected for further study by qRT-PCR and miR-146b-5p, miR-199b-5p and miR-30a-3p were different between the PTC and nodular goiter groups. miR-199b-5p was over-expressed in PTC patients with extrathyroidal invasion and cervical lymph node metastasis. In conclusion miR-146b-5p, miR-30a-3p, and miR-199b-5p may serve as biomarkers for the diagnosis of PTC and miR-199b-5p is associated with PTC invasiveness.
本研究筛选了在甲状腺乳头状癌(PTC)组织中异常表达的微小RNA(miRNA),以鉴别PTC与结节性甲状腺肿以及PTC的恶性程度。2011年6月至12月期间,从杭州市第一人民医院外科肿瘤科获取了51例甲状腺肿瘤组织标本及其配对的相邻正常甲状腺组织。通过微阵列检测miRNA表达谱,并通过定量实时聚合酶链反应(qRT-PCR)进行验证。分析miRNA的表达水平,以评估它们是否与选定的临床病理特征相关。在结节性甲状腺肿与PTC之间以及高侵袭性和低侵袭性PTC之间,有11种miRNA存在显著差异表达。miR-199b-5p和miR-30a-3p在三组之间存在显著差异表达。通过qRT-PCR选择miR-30a-3p、miR-122-5p、miR-136-5p、miR-146b-5p和miR-199b-5p进行进一步研究,且miR-146b-5p、miR-199b-5p和miR-30a-3p在PTC组和结节性甲状腺肿组之间存在差异。miR-199b-5p在伴有甲状腺外侵犯和颈部淋巴结转移的PTC患者中过度表达。总之,miR-146b-5p、miR-30a-3p和miR-199b-5p可能作为PTC诊断的生物标志物,且miR-199b-5p与PTC的侵袭性相关。